NCT07198074 · Interventional trial
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
Overall registry status Recruiting
Phase 3
Conditions Advanced Endometrial Carcinoma, Recurrent Endometrial Carcinoma
Delaware Valley sites
- Asplundh Cancer Pavilion · Willow Grove, PA · Montgomery County · Recruiting
- Cooper Hospital University Medical Center · Camden, NJ · Camden County · Recruiting
- Jefferson Torresdale Hospital · Philadelphia, PA · Philadelphia County · Recruiting
- Sidney Kimmel Cancer Center Washington Township · Sewell, NJ · Gloucester County · Recruiting
- The Cancer Institute of New Jersey Hamilton · Hamilton, NJ · Mercer County · Recruiting
- Thomas Jefferson University Hospital · Philadelphia, PA · Philadelphia County · Recruiting
First posted
Registry updated
Added to the directory